Cat. No. | Product Name / Activity |
---|---|
7104 | VH 032 amide-PEG1-acid New |
VHL ligand with PEG linker and terminal acid for onward chemistry | |
7105 | VH 032 amide-PEG5-acid New |
VHL ligand with PEG linker and terminal acid for onward chemistry | |
7106 | VH 032 amide-alkylC2-acid New |
VHL ligand with alkyl linker and terminal acid for onward chemistry | |
7107 | VH 032 amide-alkylC6-acid |
VHL ligand with alkyl linker and terminal acid for onward chemistry | |
7108 | VH 032 amide-alkylC8-acid |
VHL ligand with alkyl linker and terminal acid for onward chemistry | |
7116 | Chemerin-9, Human |
Potent CMKLR1 agonist; c-terminal peptide of full length human chemerin | |
7117 | Chemerin-9, Mouse |
Potent CMKLR1 agonist; c-terminal peptide of full length mouse chemerin | |
7119 | Sorbic acid |
Activator of hFFA2-DREADDs | |
7121 | 7-Aminoactinomycin D |
Fluorescent DNA stain | |
7131 | TM 38837 New |
Highly potent CB1 inverse agonist; peripherally restricted | |
7143 | VX 765 New |
High affinity and selective caspase-4 and caspase 1/ICE inhibitor; orally bioavailable | |
7150 | Tocriscreen 2.0 Max |
Bioactive compound library for high-throughput screening, high-content screening and chemical biology applications; comprised of 1280 biologically active compounds (250 μL 10 mM DMSO solutions) | |
7151 | Tocriscreen 2.0 Mini |
Bioactive compound library for high-throughput screening, high-content screening and chemical biology applications; comprised of 1280 compounds (50 μL 10 mM DMSO solutions) | |
7152 | Tocriscreen 2.0 Micro |
Bioactive compound library for high-throughput screening, high-content screening and chemical biology applications; comprised of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | |
7156 | WQ 1 New |
Potent and selective σ1 receptor antagonist; active in vivo | |
7158 | FMF-04-159-2 New |
Potent covalent CDK14 and CDK16 inhibitor; also inhibits other TAIRE kinase family members | |
7159 | FMF-04-159-R New |
Potent CDK14 and CDK16 inhibitor; displays reversible inhibition of CDK14 | |
7160 | DD 03-171 |
Potent and selective BTK Degrader | |
7162 | iFSP1 |
Ferroptosis suppressor protein 1 (FSP1) inhibitor; ferroptosis inducer | |
7163 | Chroman 1 |
Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogeneisis | |
7170 | D-GsMTx4 New |
TRPC1/6 and Piezo2 inhibitor; resistant to proteolytic digestion | |
7175 | DOPE New |
Liposome/lipoplex transfection reagent | |
7177 | NR 7h |
Potent and selective p38α and p38β degrader; active in vivo | |
7178 | LCL 161, phenol New |
Functionalized IAP ligand for PROTACs | |
7182 | SGC 6870 New |
Potent and selective PRMT6 inhibitor | |
7184 | SGC 6870N New |
Negative control for SGC 6870 (Cat. No. 7182) | |
7187 | Zanamivir New |
Potent influenza virus neuraminidase inhibitor | |
7188 | Carfilzomib New |
Potent irreversible proteasome inhibitor; active in vivo | |
7189 | Saracatinib New |
Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable | |
7191 | Santacruzamate A New |
Highly potent and selective HDAC2 inhibitor | |
7192 | SMIP 004 New |
SKP2 (S-phase kinase-associated protein 2) inhibitor; upregulates p27 and arrests cell cycle in G1 phase | |
7193 | Deschloroclozapine New |
High affinity and highly potent activator of hM3Dq and hM4Di DREADDs; rapidly blood brain barrier penetrant | |
7197 | JHU 37152 New |
High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | |
7198 | JHU 37160 New |
High affinity and highly potent hM3Dq and hM4Di DREADD agonist; blood brain barrier penetrant | |
7199 | (±)-Eriodictyol New |
Potent TRPV1 antagonist; also antioxidant; activates Nrf2/ARE signaling |